Andera Partners’s Evommune Inc EVMN Stock Holding History

Andera Partners’s Portfolio EVMN Stock Details EVMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$804K	Sell	97,362 -1,294,628	-93%	-$15.5M	0.46%	6
2026 Q2	$18.5M	Sell	1,391,990 -505,372	-27%	-$11.7M	8.96%	5
2026 Q1	$43.6M	Hold	1,897,362	–	–	24.66%	2
2025 Q4	$32.5M	Buy	+1,897,362	New	+$35.6M	18.39%	3

Other funds holding EVMN

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Andera Partners's EVMN Position: Q3 2026 in Review

Andera Partners reduced its Evommune Inc (EVMN) stake by 93% in Q3 2026, selling an estimated $15.5M and leaving 97,362 shares worth $804K. The position accounts for 0.46% of the portfolio, ranked #6.

Andera Partners first reported a position in EVMN in Q4 2025 and has held it in 4 quarters since. The position peaked at $43.6M in Q1 2026. 5 funds tracked by Wall St. Rank hold EVMN as of Q3 2026.

Andera Partners held 97,362 shares of Evommune Inc worth $804K as of Q3 2026.
Andera Partners sold 1,294,628 Evommune Inc shares in Q3 2026, an estimated $15.5M.
Evommune Inc made up 0.46% of Andera Partners's portfolio in Q3 2026, its #6 holding.
Andera Partners first reported a position in Evommune Inc in Q4 2025 and has held it in 4 quarters since.
Andera Partners's Evommune Inc position peaked at $43.6M in Q1 2026.
5 funds tracked by Wall St. Rank held Evommune Inc as of Q3 2026.

Based on Andera Partners's 13F filing for Q3 2026, filed 16 Oct 2026.